التفاصيل البيبلوغرافية
| العنوان: |
Additional file 1 of Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan |
| المؤلفون: |
Naoki Iijima (11252114), Junji Yamauchi (104276), Naoko Yagishita (11583), Natsumi Araya (239097), Satoko Aratani (239091), Kenichiro Tanabe (11252117), Tomoo Sato (239096), Ayako Takata (7526720), Yoshihisa Yamano (9084995) |
| سنة النشر: |
2021 |
| المجموعة: |
Smithsonian Institution: Digital Repository |
| مصطلحات موضوعية: |
Medicine, Cell Biology, Genetics, Sociology, Immunology, Marine Biology, Cancer, Science Policy, Hematology, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Human T-cell leukemia virus type 1, Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis, Neurogenic bladder, Urinary symptom score, Mirabegron |
| الوصف: |
Additional file 1. Supplementary methods. HAM-net. Table S1. HAM/TSP-bladder dysfunction symptom score (HAM-BDSS). Table S2. Osame Motor Disability Score (OMDS). Table S3. Baseline characteristics of patients with the consecutive 6-year follow-up (Set B). Table S4. Medications for urinary symptoms prescribed in patients with HAMBDSG 0–I (Set C). Table S5. Characteristics of patients for the analysis of the therapeutic effects of mirabegron (Set D). Figure S1. HAM/TSP-bladder dysfunction severity grade (HAM-BDSG). |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
unknown |
| العلاقة: |
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Clinical_course_of_neurogenic_bladder_dysfunction_in_human_T-cell_leukemia_virus_type-1-associated_myelopathy_tropical_spastic_paraparesis_a_nationwide_registry_study_in_Japan/15139223Test |
| DOI: |
10.6084/m9.figshare.15139223.v1 |
| الإتاحة: |
https://doi.org/10.6084/m9.figshare.15139223.v1Test |
| حقوق: |
CC BY + CC0 |
| رقم الانضمام: |
edsbas.A767AC48 |
| قاعدة البيانات: |
BASE |
